Cargando…

Pharmacovigilance obligations of the pharmaceutical companies in India

Detalles Bibliográficos
Autor principal:	Arora, Deepa
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038525/ https://www.ncbi.nlm.nih.gov/pubmed/21369406

Ejemplares similares

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

What are the obligations of pharmaceutical companies in a global health emergency?
por: Emanuel, Ezekiel J, et al.
Publicado: (2021)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey
por: Tang, Yalan, et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Pharmacovigilance of ayurvedic medicines in India
por: Thatte, Urmila, et al.
Publicado: (2008)

Pharmacovigilance training with focus on India
por: Olsson, Sten
Publicado: (2008)

Determining the obligations of the pharmaceutical industry during the pandemic
por: La Caze, Adam
Publicado: (2022)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Changing R&D models in research-based pharmaceutical companies
por: Schuhmacher, Alexander, et al.
Publicado: (2016)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Role of Pharmacovigilance in India: An overview
por: Suke, Sanvidhan G, et al.
Publicado: (2015)

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007)

Pharmacovigilance of Herbal Products in India
por: Wal, P, et al.
Publicado: (2011)

An update on the Pharmacovigilance Programme of India
por: Lihite, Ratan J., et al.
Publicado: (2015)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Proposal for a NIS directive 2.0: companies covered by the extended scope of application and their obligations
por: Sievers, Thomas
Publicado: (2021)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Review of the Medical Department of the East India Company
Publicado: (1830)

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
por: Nagaich, Upendra, et al.
Publicado: (2015)

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Ten Simple Rules for Internship in a Pharmaceutical Company
por: Chen, Bin
Publicado: (2014)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020)

The optimization of overall equipment effectiveness factors in a pharmaceutical company
por: Chikwendu, Okpala Charles, et al.
Publicado: (2020)

Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
por: López-Toro, Alberto A., et al.
Publicado: (2021)

Country versus pharmaceutical company interests for hepatitis C treatment
por: Lothan, Roy, et al.
Publicado: (2022)

Adverse event reporting tools and regulatory measures in India through outcome of pharmacovigilance programme of India
por: Prakash, Jai, et al.
Publicado: (2021)

Managing robotics in the bioanalytical/metabolic environment of a pharmaceutical company
por: Kushinsky, Stanley
Publicado: (1991)

A survey of pharmaceutical company representative interactions with doctors in Libya
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

The Effect of Capital Structure on the Profitability of Pharmaceutical Companies The Case of Iran
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tr6nhcgg96do3ui93keiiiok9k